Suchergebnisse - Alain Baron

Treffer weiter einschränken
  1. 1
    Improving apple juice expression and quality by pulsed electric field on an industrial scale

    Improving apple juice expression and quality by pulsed electric field on an industrial scale von Mohammad Turk, Eugène Vorobiev, Alain Baron

    Veröffentlicht 2012
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  2. 2
    Insulin resistance in the vasculature

    Insulin resistance in the vasculature von Kieren J. Mather, Helmut O. Steinberg, Alain Baron

    Veröffentlicht 2013
    Volltext Volltext
    Carta
    Zu den Favoriten
    Gespeichert in:
  3. 3
    Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans

    Endothelin Limits Insulin Action in Obese/Insulin-Resistant Humans von Amale Lteif, Prashant Vaishnava, Alain Baron, Kieren J. Mather

    Veröffentlicht 2007
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  4. 4
    Interactions Between Endothelin and Nitric Oxide in the Regulation of Vascular Tone in Obesity and Diabetes

    Interactions Between Endothelin and Nitric Oxide in the Regulation of Vascular Tone in Obesity and Diabetes von Kieren J. Mather, Amale Lteif, Helmut O. Steinberg, Alain Baron

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  5. 5
    Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression

    Antiobesity Effects of the β-Cell Hormone Amylin in Diet-Induced Obese Rats: Effects on Food Intake, Body Weight, Composition, Energy Expenditure, and Gene Expression von Jonathan D. Roth, Heather Hughes, Eric S. Kendall, Alain Baron, Christen M. Anderson

    Veröffentlicht 2006
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  6. 6
    Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes

    Endothelin Contributes to Basal Vascular Tone and Endothelial Dysfunction in Human Obesity and Type 2 Diabetes von Kieren J. Mather, Bahram Mirzamohammadi, Amale Lteif, Helmut O. Steinberg, Alain Baron

    Veröffentlicht 2002
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  7. 7
    HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose

    HbA1c Measurement Improves the Detection of Type 2 Diabetes in High-Risk Individuals With Nondiagnostic Levels of Fasting Plasma Glucose von Rachel Perry, R. Ravi Shankar, Naomi Fineberg, Janet B. McGill, Alain Baron

    Veröffentlicht 2001
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  8. 8
    Composition and properties of the polyphenolic extracts obtained from industrial plum pomaces

    Composition and properties of the polyphenolic extracts obtained from industrial plum pomaces von Michał Sójka, Krzysztof Kołodziejczyk, Joanna Milala, Maribel Abadías, İnmaculada Viñas, Sylvain Guyot, Alain Baron

    Veröffentlicht 2014
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  9. 9
    The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats

    The exenatide analogue AC3174 attenuates hypertension, insulin resistance, and renal dysfunction in Dahl salt-sensitive rats von Que Liu, Lisa A. Adams, Anatoly Broyde, Rayne Fernandez, Alain Baron, David G. Parkes

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  10. 10
    Type II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women

    Type II Diabetes Abrogates Sex Differences in Endothelial Function in Premenopausal Women von Helmut O. Steinberg, Giancarlo Paradisi, Jessica Cronin, Kristin Crowde, Annette Hempfling, Ginger Hook, Alain Baron

    Veröffentlicht 2000
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  11. 11
    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes

    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Sulfonylurea-Treated Patients With Type 2 Diabetes von John B. Buse, Robert R. Henry, Jenny Han, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron

    Veröffentlicht 2004
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  12. 12
    Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction

    Polycystic Ovary Syndrome Is Associated With Endothelial Dysfunction von Giancarlo Paradisi, Helmut O. Steinberg, Annette Hempfling, Jessica Cronin, Ginger Hook, Marguerite K. Shepard, Alain Baron

    Veröffentlicht 2001
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  13. 13
    Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans

    Quantitative Insulin Sensitivity Check Index: A Simple, Accurate Method for Assessing Insulin Sensitivity In Humans von Arie Katz, Sridhar Nambi, Kieren J. Mather, Alain Baron, Dean Follmann, Gail W. Sullivan, Michael J. Quon

    Veröffentlicht 2000
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  14. 14
    Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure

    Glucagon-like peptide-1 and the exenatide analogue AC3174 improve cardiac function, cardiac remodeling, and survival in rats with chronic heart failure von Que Liu, Christen M. Anderson, Anatoly Broyde, Clara J. Polizzi, Rayne Fernandez, Alain Baron, David G. Parkes

    Veröffentlicht 2010
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  15. 15
    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

    Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials von Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Veröffentlicht 2016
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  16. 16
    Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes

    Effect on Glycemic Control of Exenatide (Synthetic Exendin-4) Additive to Existing Metformin and/or Sulfonylurea Treatment in Patients With Type 2 Diabetes von Mark Fineman, Thomas A. Bicsak, Larry Z. Shen, Kristin Taylor, Eling Gaines, Amanda Varns, Dennis Kim, Alain Baron

    Veröffentlicht 2003
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  17. 17
    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea

    Effects of Exenatide (Exendin-4) on Glycemic Control Over 30 Weeks in Patients With Type 2 Diabetes Treated With Metformin and a Sulfonylurea von David M. Kendall, Matthew C. Riddle, Julio Rosenstock, Dongliang Zhuang, Dennis Dong Hwan Kim, Mark Fineman, Alain Baron

    Veröffentlicht 2005
    Volltext Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  18. 18
    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies

    The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies von John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron, Mark Fineman

    Veröffentlicht 2015
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  19. 19
    Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus

    Pharmacokinetics, pharmacodynamics, and safety of exenatide in patients with type 2 diabetes mellitus von Orville Kolterman, Dennis Dong Hwan Kim, Larry Z. Shen, James A. Ruggles, Loretta L. Nielsen, Mark Fineman, Alain Baron

    Veröffentlicht 2005
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:
  20. 20
    Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

    Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications von Kieren J. Mather, Alice E. Hunt, Helmut O. Steinberg, Giancarlo Paradisi, Ginger Hook, Arie Katz, Michael J. Quon, Alain Baron

    Veröffentlicht 2001
    Volltext
    Artigo
    Zu den Favoriten
    Gespeichert in:

Suchwerkzeuge: